Old Web
English
Sign In
Acemap
>
authorDetail
>
Jason E. Shpilsky
Jason E. Shpilsky
Beth Israel Deaconess Medical Center
Medicine
Osimertinib
Epidermal growth factor receptor
Pathology
Erlotinib
2
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An up-to-date evaluation of abiraterone for the treatment of prostate cancer
2021
Expert Opinion on Pharmacotherapy
Jason E. Shpilsky
Julia Stevens
Glenn J. Bubley
Show All
Source
Cite
Save
Citations (1)
Brief Report: EGFR-mutated lung cancers resistant to osimertinib through EGFR-C797S respond to 1st generation reversible EGFR inhibitors but eventually acquire EGFR-T790M/C797S in preclinical models and clinical samples
2019
Journal of Thoracic Oncology
Deepa Rangachari
Ciric To
Jason E. Shpilsky
Paul A. VanderLaan
Susumu Kobayashi
Mierzhati Mushajiang
Christie J. Lau
Cloud P. Paweletz
Geoffrey R. Oxnard
Pasi A. Jänne
Daniel B. Costa
Show All
Source
Cite
Save
Citations (21)
1